Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chylothorax and pseudochylothorax.

C S Sassoon, R W Light

Clinics in Chest Medicine

|March 1, 1985

Summary

This summary is machine-generated.

Distinguishing chylothorax and pseudochylothorax is crucial, as these conditions present with milky pleural effusions but require different treatment and have varying prognoses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.

Lymphology·2018

Same author

Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).

Canadian respiratory journal·2017

Same author

Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).

Lung·2015

Same author

Research: Why and how to write a paper?

Revista clinica espanola·2015

Same author

Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2012

Same author

Drug-induced eosinophilic pleural effusion.

European respiratory review : an official journal of the European Respiratory Society·2011

Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026

Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026

Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026

Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026

Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026

Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026

See all related articles

Area of Science:

Medicine
Pulmonology
Thoracic Surgery

Background:

Chylothorax and pseudochylothorax manifest as milky or turbid pleural effusions.
Accurate differentiation is essential for appropriate patient care.

Purpose of the Study:

To highlight the clinical significance of differentiating chylothorax from pseudochylothorax.
To underscore the distinct prognostic and therapeutic implications of each condition.

Main Methods:

Review of clinical presentations.
Analysis of diagnostic criteria for pleural effusions.
Comparison of management strategies.

Main Results:

Both conditions involve lipid-rich pleural fluid.

Related Experiment Videos

Chylothorax involves lymphatic disruption, while pseudochylothorax is often associated with chronic inflammation or malignancy.

Diagnostic methods may include fluid analysis and imaging.

Conclusions:

The distinction between chylothorax and pseudochylothorax is critical.
Misdiagnosis can lead to suboptimal or delayed treatment.
Prompt and accurate diagnosis ensures appropriate management and improves patient outcomes.